KATIE MCMENAMIN: Open Payments
NPI 1437568664 · SPRINGBORO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$868 in 46 payments from 13 companies in 2025. Trend: 2023 $1,593 · 2024 $1,076 · 2025 $868
Food & beverage: $773Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $156 |
| Janssen Biotech, Inc. | 5 | $144 |
| E.R. Squibb & Sons, L.L.C. | 9 | $137 |
| UCB, Inc. | 3 | $82 |
| Novartis Pharmaceuticals Corporation | 5 | $80 |
| GENZYME CORPORATION | 2 | $41 |
| REVANCE THERAPEUTICS, INC. | 1 | $41 |
| Incyte Corporation | 2 | $41 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
| Almirall LLC | 1 | $36 |
Products named: RINVOQ, TREMFYA, Sotyktu, Bimzelx, COSENTYX, DUPIXENT, DAXXIFY, Opzelura.
Industry payments across OH — which companies pay providers there.
